Mary Kay
This article was originally published in The Rose Sheet
Executive Summary
President and CFO David Holl is promoted to CEO, effective immediately, direct-seller announces April 24. Holl, who will retain his title as president, assumes the post from company co-founder Richard Rogers. Rogers will become chairman of the board, firm notes. In his new role, Holl will "direct all operational and fiscal initiatives for more than 4,000 Mary Kay employees worldwide who support the company's rapidly expanding independent sales force," according to the firm. Exec joined Mary Kay in 1993 and has served in various roles, becoming president and CFO in 2001 (1"The Rose Sheet" Oct. 29, 2001, In Brief)...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.